Patients’ Satisfaction with Topical Anti-Glaucoma Medications and Associated Factors at Gondar University Tertiary Eye Care and Training Center, Northwest Ethiopia, 2021

Abstract

Background

Glaucoma is one of the leading cause of global irreversible blindness if left untreated. Satisfaction is a multifaceted outcome based on sufficient information and encouragement from the practitioner and based on the medications’ nature. Determining patients’ satisfaction is essential to increase their courage in their long-time follow-up of medical care.

Objective

To assess Patients’ satisfaction with topical anti-glaucoma medications and associated factors among glaucoma patients at Gondar University Tertiary Eye Care and Training Center, Northwest Ethiopia.

Methods

Hospital-based cross-sectional study was conducted from June 30 to August 27, 2021, among 395 glaucoma patients at Gondar University Tertiary Eye Care and Training Center. Data was entered into Epi info version 7 and exported to SPSS version 26 software for analysis. A Binary logistic regression model was used to determine factors associated with satisfaction with topical anti-glaucoma medications. Statistical significance was considered when p-value < 0.05.

Results

A total of 395 study subjects participated in the study with a response rate of 93.38%. The overall satisfaction with topical anti-glaucoma medication was 62.5% with 95% CI: (57.5–67.8%). The absence of ocular side effects (AOR=5.39, 95% CI: 2.35–12.37) and the absence of ocular surface diseases (AOR=4.12, 95% CI: 1.69–10.09) were significantly associated with patient satisfaction.

Conclusion

More than half of the study participants were satisfied with topical anti-glaucoma medications. The absence of ocular side effects and absence of Ocular surface diseases were significantly associated with patient satisfaction with anti-glaucoma medication.

Keywords:

• satisfaction
• anti-glaucoma medication
• Gondar
• Northwest Ethiopia

Disclosure

The authors report no conflicts of interest in this work.